Press release
Anesthesia and Respiratory Devices Market: Increased Patient Preference Towards Reduced Hospital Stay has Propelled Growth
A rise in healthcare expenditures witnessed globally has led to a shift in preference from hospital care to home care among patients. This rise in healthcare cost, compounded by the geriatric population, is driving the demand for portable medical diagnostic devices including respiratory and anesthesia devices. This has led to a visible shift in the use of respiratory and anesthesia devices from hospital operation set ups to home care healthcare monitoring.Request a PDF Brochure with Report Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1177
Moreover, a rise in respiratory diseases such as asthma, lung cancer, COPDs (Chronic Obstructive Pulmonary Diseases) and OSA (Obstructive Sleep Apnea) have triggered the growth of this market. There has also been an exponential rise in number of surgical procedures globally and this has led to a significant growth in demand for anesthesia devices and delivery machines.
Growing healthcare cost containment pressure in the U.S. and the ongoing Euro crisis have caused a slump in the growth of these markets. Tax reforms coupled with increased regulatory compliance norms are also restraining the growth and profitability of top companies. The tax reform under question has proposed the levy of a 2.3% tax on the annual sale of all the medical devices manufacturers since beginning of this year i.e. 2013.
This has made it imperative for OEMs to tap the potential market in emerging economies such as India, China, Brazil and Russia. There has been significant growth in these emerging economies owing to increase healthcare awareness, rising disposable incomes and a rising middle class coupled with favorable insurance policies in these countries. This in turn is anticipated to make these regions the most attractive markets during the forecast period from 2011 to 2019.
The report covers in-depth analysis of estimation of anesthesia and respiratory devices market, for the period from 2013 to 2019, considering 2012 as the base year for calculations. In addition, the current market dynamics including the drivers, restraints, trends and recent developments has been captured throughout the report. The respiratory devices market has been further bifurcated under respiratory devices, respiratory disposables and respiratory measurement devices. This market has been further segmented by the respective types of devices. The anesthesia devices market has been split broadly under anesthesia machines and disposables.
The geographic chapter spans the major regions including North America, Europe, Asia and ROW (Rest of World). Similarly, market share analysis for global market for respiratory and anesthesia devices together has been provided in the competitive landscape chapter. In addition we have also separately provided the market share analysis for respiratory and anesthesia devices respectively. Some of the major players in this market are GE Healthcare, Drager, Fischer & Paykel, Covidien, Teleflex Incorporated, Philips Healthcare, ResMed and others.
Browse Research Report: http://www.transparencymarketresearch.com/anesthesia-respiratory-devices.html
These market players have been profiled on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability financial overview and recent developments. Our chapter on recommendations provides an understanding of barriers to the market entry and success strategy to be considered for growth in this market.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anesthesia and Respiratory Devices Market: Increased Patient Preference Towards Reduced Hospital Stay has Propelled Growth here
News-ID: 413884 • Views: …
More Releases from TMR

Emerging Opportunities in Logistics Market with Current Trends Analysis
The global Logistics market is estimated to attain a valuation of US$ 15,273.21 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.5% during the forecast period, 2019-2027.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the…
Energy Measurement IC Market is expected to reach US$ 8.39 Bn by the end of 2031
According to a Transparency Market Research (TMR) research report, the global energy measurement ic market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 8.39 Bn by the end of 2031.
The study on the energy measurement ic market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The…
STATCOM UPS Market to Register Double Digit Growth Rate of 16% CAGR by 2024
Over the last decade, rising number of industries and utilities are opting for static synchronous compensator or STATCOM UPS instead of static VAR compensator or SVC UPS. Low harmonic emission coupled with high speed of response is accentuating the expansion of India STATCOM UPS market now and in times to come. Playing a crucial role in voltage control and compensation of reactive power, STATCOM UPS is likely to keep its…
Thin Wafer Processing and Dicing Equipment Market US$692.5 mn by 2024 - TMR
Transparency Market Research (TMR) estimates that the global thin wafer processing and dicing equipment market has a highly consolidative landscape. Disco Corp. accounted for largest share of 56.4% in 2015 and likely to be dominant in the coming years. This is creating monopoly in the thin wafer processing and dicing equipment market in terms of competitive presence. The other key players such as EV Group, Plasma-Therm LLC, Lam Research Corp,…
More Releases for Obstructive
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market- (By Drug Class (Bronchodilators, Combination, Corticosteroids, Phosphodiesterase), By Type (Chronic Bronchitis, Emphysema), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market…
Key Influencer in the Obstructive Laryngitis Treatment Market 2025: Growing Inci …
What Is the Forecasted Market Size and Growth Rate for the Obstructive Laryngitis Treatment Market?
The market size of obstructive laryngitis treatment has witnessed robust growth in the recent past. It is projected to expand from $1.95 billion in 2024 to $2.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. The acceleration in market growth during the historic period can be accredited to increasing prevalence of diseases…
Chronic Obstructive Pulmonary Disease Pipeline Therapeutics Assessment Report 20 …
(Albany, United States) As per DelveInsight's assessment, globally, the Chronic Obstructive Pulmonary Disease pipeline constitutes 65+ key companies continuously working towards developing 70+ Chronic Obstructive Pulmonary Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
To explore more information on the latest breakthroughs in the Chronic Obstructive Pulmonary Disease Pipeline treatment landscape of the report, click here @ Chronic Obstructive…
Chronic Obstructive Pulmonary Disease Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Chronic Obstructive Pulmonary Disease Market was valued at USD 10.17 Billion in 2018 and is projected to reach USD 13.9 Billion by 2026, growing at a CAGR of 4.03% from 2019 to 2026.
Market Overview for Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmonary Disease Market OverviewChronic Obstructive Pulmonary Disease (COPD) affects millions worldwide, presenting a significant healthcare burden due to its chronic nature and progressive symptoms. The market…
Chronic Obstructive Pulmonary Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Chronic Obstructive Pulmonary Disease Pipeline Insight 2024" report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Chronic Obstructive Pulmonary…
Obstructive Lung Disease Pharmaceutical and Healthcare Analysis Information 2023
Market Highlights
The use of drugs has emerged as an effective solution for the treatment of COPD and asthma, which largely contributes to the growth of the global obstructive lung disease market. The market is driven by the growing COPD and asthmatic patient population, as well as the FDA approval for novel products and its wide acceptance. Increasing government initiatives to control COPD and asthma further, fuel the growth of this…